A Multicenter Open-Label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects Who Completed a Preceding Psoriasis Clinical Study With Adalimumab

The two objectives of this study were to evaluate long-term efficacy and safety of adalimumab treatment in participants who had moderate to severe chronic plaque psoriasis and to evaluate the effectiveness of adalimumab retreatment in participants who had therapeutic response to adalimumab and were then withdrawn from adalimumab treatment.

本研究的两项核心目标为：其一，评估阿达木单抗（Adalimumab）治疗中重度慢性斑块状银屑病受试者的长期疗效与安全性；其二，评估在对阿达木单抗产生治疗应答后中止该药物治疗的受试者中，阿达木单抗再治疗的有效性。